Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 10.98
+0.16 (1.48%)
Apr 29, 2026, 3:00 PM CST
SHA:603998 Market Cap
SHA:603998 has a market cap or net worth of 4.82 billion as of April 29, 2026. Its market cap has increased by 9.25% in one year.
Market Cap
4.82B
Enterprise Value
5.07B
Revenue
1.79B
Ranking
n/a
PE Ratio
15.68
Stock Price
10.98
Market Cap Chart
Since January 7, 2015, SHA:603998's market cap has increased from 2.80B to 4.82B, an increase of 71.90%. That is a compound annual growth rate of 4.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.82B | -2.31% |
| Dec 31, 2025 | 4.94B | 7.86% |
| Dec 31, 2024 | 4.58B | -5.06% |
| Dec 29, 2023 | 4.82B | 36.87% |
| Dec 30, 2022 | 3.52B | 20.58% |
| Dec 31, 2021 | 2.92B | 13.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuan Pharmaceutical (Group) | 4.84B |
| Bide Pharmatech | 4.81B |
| Shandong Sinobioway Biomedicine | 4.77B |
| Hubei Biocause Heilen Pharmaceutical | 4.76B |
| Jinling Pharmaceutical Company | 4.58B |
| Newland Pharmaceutical | 4.49B |
| Tibet Weixinkang Medicine | 4.49B |
| Yabao Pharmaceutical Group | 4.44B |